Back to announcements list
Target Total Dividend
RNS Number : 5617Z
Bellevue Healthcare Trust PLC
12 January 2024
 

Bellevue Healthcare Trust plc (the "Company")

 

LEI: 213800HQ3J3H9YF2UI82

 

Statement re: Target total dividend for the financial year ending 30 November 2024

 

As stated in the Company's IPO prospectus and in the Company's prospectus dated 5 November 2018, the Company aims to target a dividend each financial year equal to 3.5 per cent of the Net Asset Value as at the last day of the Company's preceding financial year.

 

The Company intends to pay dividends on a semi-annual basis, by way of two equal dividends, with dividends declared in July and paid in August / September and proposed in February / March and paid in March / April in each year.

 

For the financial year ended 30 November 2023 the Company paid an interim dividend of 2.995p per ordinary share in August 2023 and in due course the Board is intending to propose a final dividend of 2.995p per ordinary share.

 

For the financial year ending 30 November 2024, the target total dividend will be 5.04p per ordinary share, this being 3.5 per cent of the unaudited net asset value per ordinary share of 143.87p per ordinary share (including current financial year revenue items) as at 30 November 2023. The Board intends to declare an interim dividend of 2.52p per ordinary share, being half of the target total dividend for the financial year ending 30 November 2024, in July 2024 and intends to pay this dividend in August / September 2024. The Board intends to propose a final dividend of 2.52p per ordinary share for the financial year ending 30 November 2024, in February / March 2025 and intends to pay this dividend in March / April 2025.

 

The Company pays dividends from distributable reserves. This announcement of a target dividend for the financial year ending 30 November 2024 should not be taken to imply a profit forecast by the Company.

 

 

 

Enquiries:

Mark Ghahramani                                                          

Bellevue Asset Management (UK) Ltd

Tel: +44 (0)20 3871 2862

 

January 2024

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVQKBBPKBKDODD